UPCOMING SESSIONS in ET
Thu, Jun 4, 2026
5:00 – 6:00 AM Bangkok
Cardiac Amyloidosis: New Strategies for Disease-Modifying Therapies Nitasha Sarswat Click To Register
UPCOMING SESSIONS in ET
Thu, Jun 4, 2026 · 5:00 – 6:00 AM Bangkok
Cardiac Amyloidosis: New Strategies for Disease-Modifying Therapies
Nitasha Sarswat
Click To Register
View all sessions

News

The Pharma Letter
May 11, 2026
First look at Wainua in ATTR-CM Phase III CARDIO-TTRansform data
This weekend at the European Society of Cardiology’s Heart Failure 2026 Congress in Barcelona), the first data from AstraZeneca’s (LSE: AZN) Phase III CARDIO-…
Read more
amyloidosis
May 11, 2026
Eye dryness, floaters common in hATTR-PN, but more research needed
People with hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN) often experience eye-related complications such as eye dryness and floaters in the…
Read more
Newsroom
May 11, 2026
New study explores how to improve diagnosis of a frequently missed heart condition
The American Heart Association launches cluster randomized trial to improve detection of ATTR cardiomyopathy within hospitals participating in Get With The…
Read more
medscape
May 11, 2026
Long Delays in Cardiac Amyloidosis Diagnosis Persist
TOPLINE:Most older adults with transthyretin cardiac amyloidosis (ATTR-CM) experienced at least 6 months of delay in diagnosis after a first heart failure (HF)…
Read more
science direct
May 10, 2026
Apolipoprotein A-IV Cardiac Amyloidosis as a Diagnostic Pitfall: Beyond the Non-Invasive Algorithm
AbstractBackgroundCardiac amyloidosis is frequently underdiagnosed and rarer forms (e.g., non-transthyretin or light chain amyloidosis) can be challenging to…
Read more
American Heart Association Journals
May 09, 2026
Rationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy
AbstractBACKGROUND:Transthyretin amyloidosis with cardiomyopathy is a progressive, fatal disease characterized by deposition of extracellular misfolded…
Read more
Imaging Technology News
May 08, 2026
Bayer Announces Positive Data for Investigational PET Radiotracer
Recent research shows that Bayer's investigational PET radiotracer Iodine 124 Evuzamitide meets primary endpoints in Phase III study in patients suspected to…
Read more
amyloidosis
May 07, 2026
Immunoglobulin A lambda multiple myeloma– related light-chain cardiac amyloidosis presenting with progressive heart failure with preserved ejection fraction: a multimodality imaging case report
AbstractCardiac involvement is the main determinant of prognosis in immunoglobulin light-chain (AL) amyloidosis, but may be under-recognized in patients with…
Read more
Oxford Academic
May 07, 2026
MACROGLOSSIA AND PERIORBITAL PURPURA AS EARLY RED FLAGS OF AL AMYLOIDOSIS ASSOCIATED WITH MULTIPLE MYELOMA
AbstractBackgroundAL amyloidosis is a rare systemic disorder related to plasma cell dyscrasias and caused by deposition of monoclonal light chains. Cardiac…
Read more
Subscribe to